GGrantIndex
← Leaderboards

Hamed Khalili

Tufts University Boston

$7,312,402
Attributed
$10,976,257
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY201325
$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,976,257 · 4

By mechanism

UG1$7,327,710 · 1
R01$2,534,399 · 1
K23$945,648 · 1
R03$168,500 · 1

Top collaborators

Most similar at Tufts University Boston

Same institution · by research overlap

Others in their field

Top investigators on “Cohort

Research focus

CohortMicrobiomeS DiseaseRecommendationLinkEpidemiologyPublicationsSwedenInflammatoryInflammatory Bowel DiseasesIncidenceInsightEnvironmental Risk FactorBlood SpecimenEnsureMultidisciplinaryOralGeneticCommunitiesMediatingBaseChronicFecesFunding

Grant awards (16)

Clinical Center for NIH's Nutrition for Precision Health: The All Of Us New England Research Collaborative$2,399,651
UG1 · FY2025 · HD
Clinical Center for NIH's Nutrition for Precision Health: The All Of Us New England Research Collaborative$2,475,248
UG1 · FY2024 · HD
Medications, the gut microbiota, and risk of microscopic colitis$531,975
R01 · FY2024 · AG · contact PI
Clinical Center for NIH's Nutrition for Precision Health: The All Of Us New England Research Collaborative$1,898,865
UG1 · FY2023 · HD
Medications, the gut microbiota, and risk of microscopic colitis$531,961
R01 · FY2023 · AG · contact PI
Medications, the gut microbiota, and risk of microscopic colitis$615,172
R01 · FY2022 · AG · contact PI
Clinical Center for NIH's Nutrition for Precision Health: The All Of Us New England Research Collaborative$553,946
UG1 · FY2022 · HD
Medications, the gut microbiota, and risk of microscopic colitis$417,456
R01 · FY2021 · AG · contact PI
Medications, the gut microbiota, and risk of microscopic colitis$437,835
R01 · FY2020 · AG · contact PI
Anti-TNF therapy in ulcerative colitis: a comprehensive study of health-care utilizations and societal cost$84,250
R03 · FY2019 · DK · contact PI
Anti-TNF therapy in ulcerative colitis: a comprehensive study of health-care utilizations and societal cost$84,250
R03 · FY2018 · DK · contact PI
Oral Contraceptives in the Etiopathogenesis of Crohn's Disease$200,880
K23 · FY2017 · DK · contact PI
Oral Contraceptives in the Etiopathogenesis of Crohn's Disease$186,192
K23 · FY2016 · DK · contact PI
Oral Contraceptives in the Etiopathogenesis of Crohn's Disease$186,192
K23 · FY2015 · DK · contact PI
Oral Contraceptives in the Etiopathogenesis of Crohn's Disease$186,192
K23 · FY2014 · DK · contact PI
Oral Contraceptives in the Etiopathogenesis of Crohn's Disease$186,192
K23 · FY2013 · DK · contact PI